Skip to content
HC Technology
Company News

Suzhou Hengchang Biotechnology's 3,000-Ton Annual Capacity N-Methylaniline Upgrading Project Passes Safety Facility Design Review

In December 2024, the company's 3,000-ton annual capacity N-methylaniline technical upgrading project passed the safety facility design review by the Suzhou Municipal Emergency Management Bureau, following its safety conditions review approval in August 2024. Both safety review procedures are complete, laying a compliance foundation for project implementation.

In December 2024, the 3,000-ton annual capacity N-methylaniline technical upgrading project of Suzhou Hengchang Biotechnology Co., Ltd. passed the safety facility design review organized by the Suzhou Municipal Emergency Management Bureau. With this, the first two review procedures required under the safety supervision regulations for hazardous chemical construction projects have both been completed, laying a compliance foundation for subsequent project implementation.

Under the safety supervision regulations for construction projects involving hazardous chemicals, such projects must pass two procedures in sequence: a safety conditions review, which examines and validates safety conditions at the project initiation stage, and a safety facility design review, which examines and confirms the design of safety facilities. The project obtained the safety conditions review approval from the Suzhou Municipal Emergency Management Bureau on August 6, 2024 (No. Su Ying Ji Shen Pi Zhun Zi [2024] 74). With the design review now passed, the project will proceed to the engineering implementation stage as planned.

N-methylaniline is one of the company's key products, widely used as an intermediate in cationic dyes, rubber additives, and agrochemicals. Centered on capacity enhancement and process optimization, this upgrading project, once completed, will help the company improve product supply capability and better meet downstream customer demand.

Suzhou Hengchang Biotechnology Co., Ltd. is located in the chemical industry park of the Suzhou Economic Development Zone in Anhui Province, with a registered capital of 120 million CNY. It is a comprehensive enterprise focused on pharmaceutical manufacturing, covering chemical product manufacturing, new materials technology R&D, and import and export business. Guided by technological innovation and supported by intelligent manufacturing, safety, environmental protection, and standardized management, the company continues to advance its product portfolio and production processes.

Taking the implementation of this upgrading project as an opportunity, the company will strictly fulfill its workplace safety responsibilities, advance the project to high standards, continuously improve its safety and environmental management, and create long-term value for customers and society.

(Source: administrative licensing disclosures of the Suzhou Municipal Emergency Management Bureau)

December 19, 2024